首页|慢性阻塞性肺疾病急性加重患者血清Notch1、Caspase?3、ROS水平与病情严重程度及预后的关系

慢性阻塞性肺疾病急性加重患者血清Notch1、Caspase?3、ROS水平与病情严重程度及预后的关系

扫码查看
目的 研究慢性阻塞性肺疾病急性加重(AECOPD)患者血清Notch1、含半胱氨酸的天冬氨酸蛋白水解酶⁃3(Caspase⁃3)、活性氧簇(ROS)水平与病情严重程度及预后的关系.方法 选取2022年1月至2024年1月黄河三门峡医院住院治疗的96例AECOPD患者作为AECOPD组,同期门诊收治的60例稳定期COPD患者作为稳定期COPD组,同期体检的60名健康志愿者作为对照组.评估AECOPD病情并分为轻度亚组、中度亚组和重度亚组,评估AECOPD的疗效并分为有效亚组和无效亚组.检测血清Notch1、Caspase⁃3、ROS水平,比较三组间及各亚组间血清指标的差异,分析血清指标对AECOPD患者治疗预后的预测作用.结果 血清Notch1、Caspase⁃3、ROS水平的比较,AECOPD组>稳定期COPD组>对照组,差异有统计学意义(P<0.05);重度亚组>中度亚组>轻度亚组,差异有统计学意义(P<0.05);无效亚组高于有效亚组,差异有统计学意义(P<0.05).血清Notch1、Caspase⁃3、ROS水平单独及联合预测AECOPD患者治疗预后的曲线下面积(AUC)为0.754、0.626、0.846、0.976,联合预测的AUC大于单独预测(P<0.05).结论 AECOPD患者血清Notch1、Caspase⁃3、ROS水平与病情加重有关,并且对治疗预后具有预测作用.
Relationship between serum notch1,caspase?3,ROS levels and the severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease
Objective To investigate the relationship between serum levels of notch1,cysteinyl as⁃partate specific proteinase⁃3(Caspase⁃3)and reactive oxygen species(ROS)and the severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods 96 patients with AECOPD hospitalized at Sanmenxia Hospital of the Yellow River from January 2022 to January 2024 were selected as the AECOPD group,60 patients with stable COPD admitted to the outpatient department during the same period were selected as the stable COPD group,and 60 healthy volunteers who underwent physical exami⁃nations during the same period were selected as the control group.The condition of AECOPD was evaluated and divided into mild subgroup,moderate subgroup and severe subgroups.The efficacy of AECOPD was evaluated and divided into effective and ineffective subgroups.The levels of serum notch1,caspase⁃3 and ROS were de⁃tected,and the differences in serum indicators among the three groups and among the subgroups were com⁃pared,the predictive effect of serum indicators on the treatment prognosis of AECOPD patients was analyzed.Results The comparison of levels of serum notch1,caspase⁃3 and ROS were AECOPD group>stable COPD group>control group,the difference was statistically significant(F=137.485,207.391,155.692,P<0.05),se⁃vere subgroup>moderate subgroup>mild subgroup,the difference was statistically significant(F=43.595,31.586,53.182,P<0.05),the ineffective subgroup was higher than the effective subgroup,and the difference was statistically significant(t=4.586,2.289,5.937,P<0.05).The area under the curve(AUC)of serum notch1,caspase⁃3 and ROS levels independently and jointly predicted the prognosis of AECOPD patients were 0.754,0.626,0.846,0.976,and the AUC of combined prediction was greater than that of single prediction(Z=5.856,7.322,4.552,P<0.05).Conclusion The levels of serum notch1,caspase⁃3 and ROS in AECOPD pa⁃tients are related to the exacerbation of the disease and can serve as predictors of prognosis.

COPDNotch1Caspase-3ROS

张铭、柴沛

展开 >

三门峡黄河明珠(集团)有限公司职工医疗门诊部,河南,三门峡 472000

黄河三门峡医院,河南,三门峡 472000

慢性阻塞性肺疾病急性加重 Notch1 含半胱氨酸的天冬氨酸蛋白水解酶⁃3 活性氧簇

河南省医学科技攻关计划项目

LBHC21210765

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(10)